Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
25 participants
INTERVENTIONAL
2025-12-31
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Milky Way Sensor: Device Validation for Infiltrated Tissues
NCT07311733
ivWatch Sensor: Device Validation for Infiltrated Tissues
NCT04064229
ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues
NCT04065373
Optical Detection of Intravenous Infiltration
NCT01126710
Pilot Testing a Novel Non-invasive Lactate Sensor
NCT05649358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Infiltrated Tissue
The ivWatch Model 400 monitored a common peripheral IV site over a 24 hour observation period.
ivWatch Model 400
The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ivWatch Model 400
The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy individual, verified by an eligible designation on the Health History Form
Exclusion Criteria
* Currently pregnant or trying to become pregnant
* Serious and uncontrolled medical condition
* Tattoo(s), scarring, or bruising that severely limits vein visualization at a sensor monitoring location
* Medical adhesive allergy
* Sleepwalking occurrence in the last year
* Current drug/alcohol dependence
* Sick or had an infection in the last 14 days
* Hospitalized in the last 14 days
* Fever at the time of study visit (≥100.4°F)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ivWatch, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IVW-CLR-CS37-400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.